ArticleScientific reports2026
Salivary immune alteration persists after caries treatment.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Dental caries is a highly prevalent disease involving complex local immune alterations that contribute to its progression and resolution. The objective of this study was to evaluate the effect of dental treatment on the salivary immunoproteome in individuals with dental caries using a longitudinal, group-level proteomic approach based on biological pooling, and to descriptively explore associated changes in salivary bacterial composition. Stimulated and unstimulated saliva samples were collected from 46 participants across three clinical phases: diagnosis, post-non-invasive/microinvasive treatment, and post-invasive/restorative treatment. Proteomic profiling was performed using nLC-MS/MS, while salivary bacterial composition was assessed descriptively by MALDI-TOF MS-based identification. Data analysis included functional enrichment and pathway-level characterization. The results indicate a progressive normalization of several immune-related pathways following treatment, whereas neutrophil degranulation remained active with a reconfigured protein composition. Nine proteins, including secretory leukocyte protease inhibitor (SLPI) and mucin 7 (MUC7), remained differentially abundant across all clinical phases, defining a stable immunoproteomic pattern associated with caries susceptibility. Overall, these findings indicate that dental treatment modulates the salivary immunoproteome and highlight persistent immune features that may reflect a post-treatment adaptive state, supporting the relevance of the SLPI-MUC7 axis as a potential indicator of host susceptibility to dental caries.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.